文献
J-GLOBAL ID:202102216331099753
整理番号:21A2217492
BRCA2変異-前立腺神経内分泌癌およびMDM2増幅を有する患者におけるプラチナベースの化学療法に対する顕著な反応
Prominent response to platinum-based chemotherapy in a patient with BRCA2 mutant-neuroendocrine prostate cancer and MDM2 amplification
著者 (8件):
Daimon Tatsuaki
(Department of Urology, Keio University School of Medicine, Tokyo, Japan)
,
Kosaka Takeo
(Department of Urology, Keio University School of Medicine, Tokyo, Japan)
,
Hongo Hiroshi
(Department of Urology, Keio University School of Medicine, Tokyo, Japan)
,
Aimono Eriko
(Genomics Unit, Keio Cancer Center, Keio University School of Medicine, Tokyo, Japan)
,
Nakamura Kohei
(Genomics Unit, Keio Cancer Center, Keio University School of Medicine, Tokyo, Japan)
,
Mikami Shuji
(Division of Diagnostic Pathology, Keio University Hospital, Tokyo, Japan)
,
Nishihara Hiroshi
(Genomics Unit, Keio Cancer Center, Keio University School of Medicine, Tokyo, Japan)
,
Oya Mototsugu
(Department of Urology, Keio University School of Medicine, Tokyo, Japan)
資料名:
IJU Case Reports (Web)
(IJU Case Reports (Web))
巻:
4
号:
4
ページ:
216-219
発行年:
2021年
JST資料番号:
U1758A
ISSN:
2577-171X
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)